The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
APEC: Efficacy and toxicity of anlotinib plus PD-1 inhibitors as later-line therapy in advanced/metastatic esophageal squamous cell carcinoma (ESCC): A retrospective real-world study.
 
Jun Liu
No Relationships to Disclose
 
Xiumei Ma
No Relationships to Disclose
 
Jianguo Wu
No Relationships to Disclose
 
Ming Zhang
No Relationships to Disclose
 
Hongxuan Li
No Relationships to Disclose
 
Yan Cheng
No Relationships to Disclose
 
Xiaolong Fu
No Relationships to Disclose